Showing results (21-30 of 86) with videos related to
Sort By:
Pageof 9
International Journal of Molecular Sciences|April 3, 2021
MIAT Is an Upstream Regulator of NMYC and the Disruption of the MIAT/NMYC Axis Induces Cell Death in NMYC Amplified Neuroblastoma Cell LinesBarbara Feriancikova, Tereza Feglarova, Lenka Krskova, et al.Current Drug Metabolism|March 30, 2012
From amino acids to proteins as targets for metal-based drugsOndrej Zitka, Marketa Ryvolova, Jaromir Hubalek, et al.International Journal of Oncology|May 13, 2015
The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cellsTomas Groh, Jan Hrabeta, Mohammed Ashraf Khalil, et al.Electrophoresis|March 23, 2011
Chip gel electrophoresis as a tool for study of matrix metalloproteinase 9 interaction with metallothioneinOndrej Zitka, Sona Krizkova, Dalibor Huska, et al.Current Drug Metabolism|May 22, 2013
Nanocarriers for anticancer drugs--new trends in nanomedicineJana Drbohlavova, Jana Chomoucka, Vojtech Adam, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 16, 2003
Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factorsJosef Zamecnik, Matija Snuderl, Tomas Eckschlager, et al.International Journal of Molecular Sciences|June 8, 2013
Serum metallothioneins in childhood tumours-a potential prognostic markerJarmila Kruseova, David Hynek, Vojtech Adam, et al.Biochimica Et Biophysica Acta. Reviews on Cancer|February 2, 2019
Prostate cancer-specific hallmarks of amino acids metabolism: Towards a paradigm of precision medicineVladislav Strmiska, Petr Michalek, Tomas Eckschlager, et al.Neuro Endocrinology Letters|January 13, 2016
Cytotoxicity of and DNA adduct formation by ellipticine and its micellar form in human leukemia cells in vitroMarie Stiborova, Zuzana Manhartova, Petr Hodek, et al.Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 11, 2019
Nanodrugs used in cancer therapyKaterina Kopeckova, Tomas Eckschlager, Jakub Sirc, et al.Pageof 9